Phase I Study of Safety and Immunogenicity of ADU-623

NCT01967758 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Astrocytic Tumors
Glioblastoma Multiforme
Anaplastic Astrocytoma
Brain Tumor

Interventions

BIOLOGICAL: Cohort 1
BIOLOGICAL: Cohort 2
BIOLOGICAL: Cohort 3
DRUG: Antibiotics

Sponsor

Providence Health & Services

Collaborators

[object Object]